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Dear Editor,
After traumatic freshwater submer-
sion, severe respiratory failure and
destructive lung injury are dreaded
complications [1]. If conventional
treatment fails to provide adequate
oxygenation, veno-venous extracor-
poreal membrane oxygenation
(VV-ECMO) is the only remaining
treatment modality [2]. Yet, in the
presence of concomitant trauma, the
need for anticoagulation in
VV-ECMO poses a therapeutic
dilemma [3]. Here, we report two
trauma patients treated with mobile
VV-ECMO after freshwater aspira-
tion despite an increased trauma-
related bleeding risk.
A 33-year-old healthy male fell off
a tilted wagon, lost consciousness,
and suffered from freshwater sub-
mersion, resulting in brain and lung
contusion, and an injury severity
score (ISS) of 26. Despite lung-pro-
tective ventilation and prone position,
respiratory failure progressed
(Murray score 3.0 [4]) and
VV-ECMO was initiated within 24 h
after admission. The further clinical
course was uneventful and no addi-
tional pulmonary complications
occurred. Successful weaning from
ECMO was accomplished on day 11,
followed by intensive care unit (ICU)
discharge on day 13.
A 24-year-old healthy male expe-
rienced freshwater aspiration after a
quad bike accident, resulting in
bilateral brain contusion, lung contu-
sion, rib fractures, bilateral
pneumothoraces, and splenic rupture
grade II/VI (ISS 29). On day 6, the
respiratory condition deteriorated
(Murray score 3.5 [4]), necessitating
VV-ECMO. The subsequent clinical
course was complicated by persistent
pneumothoraces, multiple pulmonary
abscesses, empyema, and parenchy-
mal destruction (Fig. 1a–c),
ultimately allowing successful wean-
ing from VV-ECMO (day 54),
mechanical ventilation (day 66) and
ICU discharge (day 69).
In both patients, referral on
mechanical ventilation from the pri-
mary hospital to a tertiary academic
center was considered impossible
because of respiratory instability.
Therefore, our mobile team compris-
ing two experienced senior
intensivists, an ICU nurse, and a
perfusionist initiated VV-ECMO
Fig. 1 Serial chest CT scans on day 34 (a), 46 (b), and 58 (c) of VV-ECMO support in the
24-year-old male showing gradual improvement of pulmonary injury. Mobile VV-ECMO
equipment mounted on the transport trolley (d). Bi-caval dual lumen catheter (e) optimally
positioned under echocardiographic guidance into the inferior vena cava (IVC) (f) with its
single infusion port (e inset, f circle) overlying the right atrium (RA) and directed towards
the tricuspid valve. L indicates liver
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Life Support, Maquet
, Fig. 1d). One
intensivist introduced a 27-French bi-
caval dual lumen catheter (Avalon
Elite, Avalon Laboratories
, Fig. 1e)
via the right internal jugular vein,
resulting in a blood ﬂow of 4 L/min.
Optimal catheter positioning was
guided echocardiographically by the
second intensivist adhering to a pro-
tocolized combined transthoracic-
transesophageal approach using our
mobile equipment (Philips CX 50)
(Fig. 1f) [5]. The use of a single
insertion site minimized the risk of
cannula displacement, introduction of
site bleeding, and infection while
facilitating patient handling. In both
patients no VV-ECMO related com-
plications occurred.
Considering the bleeding risk due
to concomitant multitrauma, thera-
peutic anticoagulation was
undesirable [3]. Consequently, the
ﬁrst patient received a half-therapeu-
tic dose of unfractionated heparin
intravenously (5,000 IU bolus), the
second acetylsalicylic acid (100 mg)
orally (300 mg bolus). In the absence
of hemorrhagic complications, both
patients switched to a therapeutic
dosage of unfractionated heparin 48 h
after the start of VV-ECMO.
Severe but potentially reversible
pulmonary injury can successfully be
treated with VV-ECMO in trauma-
related freshwater submersion. The
combined advantages of mobile, off-
center VV-ECMO initiation using a
bi-caval dual lumen catheter in
trauma patients have, to the best of
our knowledge, not been described
before. As pointed out earlier, this
approach should be considered as a
valid therapeutic option in this cate-
gory of patients despite the assumed
increased bleeding risk associated
with multitrauma.
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